Expedia elects Henrique Dubugras to board; continues to cure audit committee independence gap

Expedia Group, Inc.

Henrique Dubugras, co-CEO of Brex, elected to Expedia board effective Oct. 27, 2022, filling vacancy from Susan Athey's June resignation.
Board now majority independent per Nasdaq Rule 5605(b)(1); company notified Nasdaq and regained compliance.
Expedia still relies on cure period under Nasdaq Rule 5605(c)(4) for audit committee composition after Julie Whalen's resignation as CFO.
Company intends to appoint additional independent director to fill Audit Committee vacancy as expeditiously as possible.

item 3.01 item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Henrique Dubugras

Director

EXPE · Expedia Group, Inc.

Effective: 2022-10-27
Filed: October 31, 2022, 7:59 PM ET

On October 27, 2022, the Board, (including a majority of the directors elected by holders of the Company’s common stock and Class B common stock, voting as a single class) elected Henrique Dubugras to fill the vacancy created by Ms. Athey’s resignation, effective immediately

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Henrique Dubugras was elected as Director at Expedia Group, Inc..

Action: elected
Role: Director

Exact text from the filing

On October 27, 2022, the Board, (including a majority of the directors elected by holders of the Company’s common stock and Class B common stock, voting as a single class) elected Henrique Dubugras to fill the vacancy created by Ms. Athey’s resignation, effective immediately

View on SEC.gov

Expedia Group, Inc. filing history →

Source: SEC EDGAR

accession 0001324424-22-000059

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.